Authors/Disclosures
|
Lin Zhang, MD, PhD, FAAN
(UCDMC)
|
Dr. Zhang has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for supernus. Dr. Zhang has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for supernus. The institution of Dr. Zhang has received research support from Michael J. Fox Foundation. |
|
|
No disclosure on file |
|
|
No disclosure on file |
|
|
No disclosure on file |
|
Ya Zhang
("GlaxoSmithKline(China) Investment Co., Ltd")
|
No disclosure on file |
|
Fu-Dong Shi, MD, PhD
(St. Joseph's Hospital and Medical Center)
|
No disclosure on file |
|
Fu-Dong Shi, MD, PhD
(St. Joseph's Hospital and Medical Center)
|
No disclosure on file |
|
|
No disclosure on file |
|
Sarah S. Wang, PhD
(University of California San Francisco)
|
Dr. Wang has nothing to disclose. |
|
Mamatha Pasnoor, MD, FAAN
|
Dr. Pasnoor has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Argenx BVBA. Dr. Pasnoor has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen Pharmaceutical. Dr. Pasnoor has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Immunovant. Dr. Pasnoor has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Pasnoor has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Annexon. Dr. Pasnoor has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Grifols. Dr. Pasnoor has received personal compensation in the range of $500-$4,999 for serving as a Consultant for amgen. |
|
Steven J. Kittner, MD, MPH
(Dept of Neurology)
|
The institution of Dr. Kittner has received research support from NINDS. |
|
Peter Como, MD
|
No disclosure on file |
|
|
No disclosure on file |
|
Karl D. Kieburtz, MD
(University of Rochester Medical Center)
|
Dr. Kieburtz has received personal compensation for serving as an employee of Clintrex Research Corporation. Dr. Kieburtz has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Kieburtz has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lilly. Dr. Kieburtz has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen. Dr. Kieburtz has stock in Clintrex Research Corp. Dr. Kieburtz has stock in Hoover Brown. An immediate family member of Dr. Kieburtz has stock in Hoover Brown. Dr. Kieburtz has stock in Safe Therapeutics. The institution of Dr. Kieburtz has received research support from NIH. The institution of Dr. Kieburtz has received research support from Michae J Fox Foundation. |